Yolk, also known as In One Basket Limited, is a pioneering company revolutionizing the food and coffee experience for people on the move. They provide high-quality sandwiches, salads, and improved breakfast options without the premium cost, boasting five successful locations in London and three upcoming openings in the second half of 2023
days to go:
TBC
investment:
Withheld
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go:
Extended
investment:
£295,000
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go:
Extended
investment:
Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go:
TBC
investment:
£127,001
A craft soft drinks brand bursting with flavour, low in sugar and a healthy, natural choice. GUNNA currently has 4 unique flavours available in cans with over 500,000 units sold across more than 2000 independent retailers. GUNNA has won two esteemed Zenith Global Innovations awards and has increased revenue by 300% compared to 2017.
days to go:
Expired
investment:
£819,150
Fireaway pizza orginally started out as a modest pizzeria in south London in 2016, we've expanded to 159 franchises, achieving a remarkable 106% compound annual growth rate in store expansion. With franchise sales reaching £59 million annually, we became debt-free in 2022, boasting an EBITDA of £1.31 million and HQ revenue of £14.5 million in FY23. As a profitable venture, we invite you to join us and be part of our promising growth trajectory.
days to go:
Expired
investment:
£532,336
Docandu is an innovative digital health platform designed both for patients & doctors, making digital healthcare accessible from anywhere. Docandu aims to be a key tech health service provider, starting from Greece, improving the existing national and private health care services. The global digital health market is estimated to be worth $536 Billion by 2025. To date, they have developed two separate apps for doctors and patients. They have also received an angel investment of 100,000 Euros and sponsorship of $25,000 from Microsoft. The company has initiated early-stage relationships with a couple of Greek public and private health entities. With the proceeds, they will execute their go-to-market strategy and make global health ID a reality, by expanding its affiliate network of doctors, health providers and public health systems.
days to go:
Expired
investment:
£70,900
Red Squirrel Group is made up of a Brewery, 3 craft beer shops and a distribution network. They are currently on target to grow their revenues by 90%. The Red Squirrel Group aim to upscale their brewery operations to 10 locations.
days to go:
Expired
investment:
£651,100
Left Handed Giant is a brewery that produces canned craft beer. They have evolved from cookery brewing to last year installing their own brewery in Bristol. The investment will help them to secure a new premise where they can double their current brewing capacity, add a bar, restaurant, outside court yard and an events space. Their aim is to create a world class brewery for people to come and experience.
(EIS Pending)
days to go:
Expired
investment:
£1,050,300
Skinny Tonic™ is the first Zero Calorie, Nothing Artificial, and Zero Sugar, 100 % Natural Tonic Water in the UK. It has a nationwide listing in Asda and a 2nd major listing agreed for 2020. Skinny Tonic™ also has been listed in major retailers including Amazon and Costco. The company has a bespoke, fully automated production facility capable of producing 6,000 cans per hour. With the proceeds, the company will recruit a marketing and sales team. Additionally, Skinny Tonic™ will increase its product development and production capacity.
days to go:
Expired
investment:
£1,783,994
